← All organizations

Silence Therapeutics GmbH

For profitWebsite ↗

Also known as: Silence Therapeutics | Silence Therapeutics plc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2022

Timeline

1990s

Jun 1, 1999
Silence Therapeutics GmbH— Founded

2000s

Dec 16, 2009
Intradigm— Acquired

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Intradigm

Recent trials (9)

NCT05537571Lead sponsorPhase 2Dec 31, 2022
NCT05499013Lead sponsorPhase 1/Phase 2Oct 31, 2022
NCT04718844Lead sponsorPhase 1Apr 14, 2021
NCT04606602Lead sponsorPhase 1Nov 18, 2020
NCT04559971Study directorEarly Phase 1Sep 3, 2020
NCT04559971Lead sponsorEarly Phase 1Sep 3, 2020
NCT04176653Lead sponsorPhase 1Aug 20, 2019
NCT01808638Lead sponsorPhase 1/Phase 2Mar 1, 2013
NCT00938574Lead sponsorPhase 1Jun 1, 2009

Details

Founded: London, GB Jun 1, 1999
Last known activity: Dec 31, 2022